Differential effect of N-(phosphonacetyl)-L-aspartate on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in human leukemia and normal bone marrow progenitors

Cancer Res. 1982 Oct;42(10):4007-13.

Abstract

The effect of N-[phosphonacetyl]-L-aspartate (PALA) on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine (ara-C) was studied in the human promyelocytic leukemic cell line, HL-60, and in normal human bone marrow. HL-60 cells exposed to 0.1 mM PALA for 12 hr accumulated 58.7 pmol ara-C per 10(6) cells after a 45-min exposure to 1 microM ara-C, compared to 27.8 pmol ara-C per 10(6) cells in untreated control cells. This PALA concentration and exposure interval was associated with a greater than 2-fold increase in both the 45-min generation and 4-hr retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate compared to untreated control HL-60 cells. Exposure of HL-60 cells to PALA followed by ara-C produced greater than additive effects on the inhibition of DNA synthesis, the inhibition of cell growth, and clonogenicity. In contrast, exposure of normal human bone marrow to the same PALA-ara-C schedule was not associated with a synergistic inhibition of colony-forming units in soft agar. If these perturbations also occur in vivo, an improvement in the therapeutic index of ara-C in patients with acute leukemia might result.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Aspartic Acid / analogs & derivatives*
  • Aspartic Acid / metabolism
  • Aspartic Acid / pharmacology
  • Bone Marrow / drug effects
  • Bone Marrow / metabolism*
  • Cell Line
  • Cells, Cultured
  • Cytarabine / metabolism*
  • DNA Replication / drug effects
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / metabolism*
  • Humans
  • Leukemia, Myeloid, Acute / metabolism*
  • Organophosphorus Compounds / pharmacology*
  • Phosphonoacetic Acid / analogs & derivatives
  • Phosphonoacetic Acid / metabolism
  • Phosphonoacetic Acid / pharmacology*

Substances

  • Antimetabolites, Antineoplastic
  • Organophosphorus Compounds
  • Cytarabine
  • Aspartic Acid
  • sparfosic acid
  • Phosphonoacetic Acid